Charles Explorer logo
🇬🇧

Avacopan jako přídatná terapie ANCA asociované vaskulitidy

Publication at First Faculty of Medicine |
2020

This text is not available in the current language. Showing version "cs".Abstract

Souhrn s komentářem. Citace: Merkel PA, Niles J, Jimenez R, Spiera RF, et al.; CLASSIC Investigators.

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. ACR Open Rheumatol 2020;2:662-671.